<record>
  <datafield tag="024" ind1="7" ind2=" ">
    <subfield code="a">10.1016/j.apradiso.2017.02.001</subfield>
    <subfield code="2">DOI</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">O’Hara, Matthew J.</subfield>
    <subfield code="v">Pacific Northwest National Laboratory, 902 Battelle Blvd., PO Box 999, Richland, WA, 99352, USA</subfield>
    <subfield code="m">matthew.ohara@pnnl.gov</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">An automated flow system incorporating in-line acid dissolution of bismuth metal from a cyclotron irradiated target assembly for use in the isolation of astatine-211</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2017-04</subfield>
    <subfield code="t">published</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">9</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Astatine-211 ( 211 At) is a promising cyclotron-produced radionuclide being investigated for use in targeted alpha therapy. The wet chemical isolation of trace quantities of 211 At, produced within several grams of Bi metal deposited onto an aluminum cyclotron target assembly, involves a multi-step procedure. Because the 211 At isolation method is labor-intensive and complex, automation of the method is being developed to facilitate routine processing at the University of Washington and to make it easier to transfer the process to other institutions. As part of that automation effort, a module useful in the initial step of the isolation procedure, dissolution of the Bi target, was designed and tested. The computer-controlled module performs in-line dissolution of Bi metal from the target assembly using an enclosed target dissolution block, routing the resulting solubilized 211 At/Bi mixture to the subsequent process step. The primary parameters involved in Bi metal solubilization (influent HNO 3 concentration and flow rate) were optimized prior to evaluation of the system using replicate 211 At-bearing cyclotron irradiated targets. The results indicate that the system performs in a predictable and reproducible manner, with cumulative Bi and 211 At recoveries following a sigmoidal function.</subfield>
    <subfield code="9">Elsevier</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="f">© 2017 Elsevier Ltd. All rights reserved.</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Astatine-211, 211 At</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Cyclotron target</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Radioimmunotherapy</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Targeted alpha therapy</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Laboratory automation</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Bismuth metal dissolution</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Astatine-211, 211At</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Krzysko, Anthony J.</subfield>
    <subfield code="v">Pacific Northwest National Laboratory, 902 Battelle Blvd., PO Box 999, Richland, WA, 99352, USA</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Niver, Cynthia M.</subfield>
    <subfield code="v">Pacific Northwest National Laboratory, 902 Battelle Blvd., PO Box 999, Richland, WA, 99352, USA</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Morrison, Samuel S.</subfield>
    <subfield code="v">Pacific Northwest National Laboratory, 902 Battelle Blvd., PO Box 999, Richland, WA, 99352, USA</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Owsley, Stanley L.</subfield>
    <subfield code="v">Pacific Northwest National Laboratory, 902 Battelle Blvd., PO Box 999, Richland, WA, 99352, USA</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Hamlin, Donald K.</subfield>
    <subfield code="v">Department of Radiation Oncology, University of Washington, 1959 NE Pacific St, Seattle, WA, 98195, USA</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Dorman, Eric F.</subfield>
    <subfield code="v">Department of Radiation Oncology, University of Washington, 1959 NE Pacific St, Seattle, WA, 98195, USA</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Scott Wilbur, D.</subfield>
    <subfield code="v">Department of Radiation Oncology, University of Washington, 1959 NE Pacific St, Seattle, WA, 98195, USA</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="p">Appl.Radiat.Isot.</subfield>
    <subfield code="c">202-210</subfield>
    <subfield code="v">122</subfield>
    <subfield code="y">2017</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">HEP</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">Citeable</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">Published</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Allen, B.J.</subfield>
    <subfield code="h">Raja, C.</subfield>
    <subfield code="h">Rizvi, S.</subfield>
    <subfield code="h">Li, Y.</subfield>
    <subfield code="h">Tsui, W.</subfield>
    <subfield code="h">Zhang, D.</subfield>
    <subfield code="h">Song, E.</subfield>
    <subfield code="h">Qu, C.F.</subfield>
    <subfield code="h">Kearsley, J.</subfield>
    <subfield code="h">Graham, P.</subfield>
    <subfield code="h">Thompson, J.</subfield>
    <subfield code="t">Targeted alpha therapy for cancer</subfield>
    <subfield code="v">49</subfield>
    <subfield code="y">2004</subfield>
    <subfield code="o">Allen et al, 2004</subfield>
    <subfield code="s">Phys.Med.Biol.,49,3703</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Alliot, C.</subfield>
    <subfield code="h">Cherel, M.</subfield>
    <subfield code="h">Barbet, J.</subfield>
    <subfield code="h">Sauvage, T.</subfield>
    <subfield code="h">Montavon, G.</subfield>
    <subfield code="t">Extraction of astatine-211 in diisopropylether (DIPE)</subfield>
    <subfield code="v">97</subfield>
    <subfield code="y">2009</subfield>
    <subfield code="o">Alliot et al, 2009</subfield>
    <subfield code="s">Radiochim.Acta,97,161</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Amado, S.</subfield>
    <subfield code="h">Blakelock, L.</subfield>
    <subfield code="h">Holmes, A.J.</subfield>
    <subfield code="h">Williams, D.L.H.</subfield>
    <subfield code="t">Kinetics and mechanism of the formation and reactions of S-nitroso derivatives of some heterocyclic thiones</subfield>
    <subfield code="v">2</subfield>
    <subfield code="y">2001</subfield>
    <subfield code="o">Amado et al, 2001</subfield>
    <subfield code="s">J.Chem.Soc.Perkin Trans.,2,441</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Andersson, H.</subfield>
    <subfield code="h">Cederkrantz, E.</subfield>
    <subfield code="h">Bäck, T.</subfield>
    <subfield code="h">Divgi, C.</subfield>
    <subfield code="h">Elgqvist, J.</subfield>
    <subfield code="h">Himmelman, J.</subfield>
    <subfield code="h">Horvath, G.</subfield>
    <subfield code="h">Jacobsson, L.</subfield>
    <subfield code="h">Jensen, H.</subfield>
    <subfield code="h">Lindegren, S.</subfield>
    <subfield code="h">Palm, S.</subfield>
    <subfield code="h">Hultborn, R.</subfield>
    <subfield code="t">Intraperitoneal α-particle radioimmunotherapy of ovarian cancer patients: Pharmacokinetics and dosimetry of 211At-MX35 F(ab′)2—A phase I study</subfield>
    <subfield code="v">50</subfield>
    <subfield code="y">2009</subfield>
    <subfield code="o">Andersson et al, 2009</subfield>
    <subfield code="s">J.Nucl.Med.,50,1153</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Aneheim, E.</subfield>
    <subfield code="h">Albertsson, P.</subfield>
    <subfield code="h">Bäck, T.</subfield>
    <subfield code="h">Jensen, H.</subfield>
    <subfield code="h">Palm, S.</subfield>
    <subfield code="h">Lindegren, S.</subfield>
    <subfield code="t">Automated astatination of biomolecules – a stepping stone towards multicenter clinical trials</subfield>
    <subfield code="v">5</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">Aneheim et al, 2015a</subfield>
    <subfield code="s">Sci.Rep.,5,1</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Aneheim, E.</subfield>
    <subfield code="h">Jensen, H.</subfield>
    <subfield code="h">Albertsson, P.</subfield>
    <subfield code="h">Lindegren, S.</subfield>
    <subfield code="t">Astatine-211 labeling: a study towards automatic production of astatinated antibodies</subfield>
    <subfield code="v">303</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">Aneheim et al, 2015b</subfield>
    <subfield code="s">J.Radio.Nucl.Chem.,303,979</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Arakaki, T.</subfield>
    <subfield code="h">Miyake, T.</subfield>
    <subfield code="h">Hirakawa, T.</subfield>
    <subfield code="h">Sakugawa, H.</subfield>
    <subfield code="t">pH dependent photoformation of hydroxyl radical and absorbance of aqueous-phase N(III) (HNO2 and NO2-)</subfield>
    <subfield code="v">33</subfield>
    <subfield code="y">1999</subfield>
    <subfield code="o">Arakaki et al, 1999</subfield>
    <subfield code="s">Environ.Sci.Technol.,33,2561</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Bäck, T.A.</subfield>
    <subfield code="h">Chouin, N.</subfield>
    <subfield code="h">Lindegren, S.</subfield>
    <subfield code="h">Kahu, H.</subfield>
    <subfield code="h">Jensen, H.</subfield>
    <subfield code="h">Albertsson, P.</subfield>
    <subfield code="h">Palm, S.</subfield>
    <subfield code="t">Cure of human ovarian carcinoma solid xenografts by fractionated [211At] alpha-radioimmunotherapy: influence of tumor absorbed dose and effect on long-term survival</subfield>
    <subfield code="y">2016</subfield>
    <subfield code="m">(10.2967/jnumed.116.178327)</subfield>
    <subfield code="o">Bäck et al, 2016</subfield>
    <subfield code="s">J.Nucl.Med.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Balkin, E.R.</subfield>
    <subfield code="h">Hamlin, D.K.</subfield>
    <subfield code="h">Gagnon, K.</subfield>
    <subfield code="h">Chyan, M.-K.</subfield>
    <subfield code="h">Pal, S.</subfield>
    <subfield code="h">Watanabe, S.</subfield>
    <subfield code="h">Wilbur, D.S.</subfield>
    <subfield code="t">Evaluation of a wet chemistry method for isolation of cyclotron produced [211At]astatine</subfield>
    <subfield code="v">3</subfield>
    <subfield code="y">2013</subfield>
    <subfield code="o">Balkin et al, 2013</subfield>
    <subfield code="s">Appl.Sci.,3,636</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Barbet, J.</subfield>
    <subfield code="h">Chatal, J.-F.</subfield>
    <subfield code="t">The best radionuclide for radioimmunotherapy of small tumors: beta- or alpha-emitter?</subfield>
    <subfield code="v">38</subfield>
    <subfield code="y">2011</subfield>
    <subfield code="o">Barbet and Chatal, 2011</subfield>
    <subfield code="s">Eur.J.Nucl.Med.Mol.Imaging,38,271</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Behr, T.M.</subfield>
    <subfield code="h">Béhé, M.</subfield>
    <subfield code="h">Stabin, M.G.</subfield>
    <subfield code="h">Wehrmann, E.</subfield>
    <subfield code="h">Apostolidis, C.</subfield>
    <subfield code="h">Molinet, R.</subfield>
    <subfield code="h">Strutz, F.</subfield>
    <subfield code="h">Fayyazi, A.</subfield>
    <subfield code="h">Wieland, E.</subfield>
    <subfield code="h">Gratz, S.</subfield>
    <subfield code="h">Koch, L.</subfield>
    <subfield code="h">Goldenberg, D.M.</subfield>
    <subfield code="h">Becker, W.</subfield>
    <subfield code="t">High-linear energy transfer (let) α versus low-let β emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab′ fragments in a human colonic cancer model</subfield>
    <subfield code="v">59</subfield>
    <subfield code="y">1999</subfield>
    <subfield code="o">Behr et al, 1999</subfield>
    <subfield code="s">Cancer Res.,59,2635</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Cotton, F.A.</subfield>
    <subfield code="h">Wilkinson, G.</subfield>
    <subfield code="t">Nitrogen: Group VA (15), Advanced Inorganic Chemistry</subfield>
    <subfield code="p">John Wiley &amp; Sons New York</subfield>
    <subfield code="y">1988</subfield>
    <subfield code="o">Cotton and Wilkinson, 1988</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Couturier, O.</subfield>
    <subfield code="h">Supiot, S.</subfield>
    <subfield code="h">Degraef-Mougin, M.</subfield>
    <subfield code="h">Faivre-Chauvet, A.</subfield>
    <subfield code="h">Carlier, T.</subfield>
    <subfield code="h">Chatal, J.F.</subfield>
    <subfield code="h">Davodeau, F.</subfield>
    <subfield code="h">Cherel, M.</subfield>
    <subfield code="t">Cancer radioimmunotherapy with alpha-emitting nuclides</subfield>
    <subfield code="v">32</subfield>
    <subfield code="y">2005</subfield>
    <subfield code="o">Couturier et al, 2005</subfield>
    <subfield code="s">Eur.J.Nucl.Med.Mol.Imaging,32,601</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Dahle, J.</subfield>
    <subfield code="h">Abbas, N.</subfield>
    <subfield code="h">Bruland, O.S.</subfield>
    <subfield code="h">Larsen, R.H.</subfield>
    <subfield code="t">Toxicity and relative biological effectiveness of alpha emitting radioimmunoconjugates</subfield>
    <subfield code="v">4</subfield>
    <subfield code="y">2011</subfield>
    <subfield code="o">Dahle et al, 2011</subfield>
    <subfield code="s">Curr.Radio.,4,321</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Gagnon, K.</subfield>
    <subfield code="h">Risler, R.</subfield>
    <subfield code="h">Pal, S.</subfield>
    <subfield code="h">Hamlin, D.</subfield>
    <subfield code="h">Orzechowski, J.</subfield>
    <subfield code="h">Pavan, R.</subfield>
    <subfield code="h">Zeisler, S.</subfield>
    <subfield code="h">Wilbur, D.S.</subfield>
    <subfield code="t">Design and evaluation of an external high-current target for production of 211At</subfield>
    <subfield code="v">55</subfield>
    <subfield code="y">2012</subfield>
    <subfield code="o">Gagnon et al, 2012</subfield>
    <subfield code="s">J.Label.Compd.Radio.,55,436</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Green, D.J.</subfield>
    <subfield code="h">Shadman, M.</subfield>
    <subfield code="h">Jones, J.C.</subfield>
    <subfield code="h">Frayo, S.L.</subfield>
    <subfield code="h">Kenoyer, A.L.</subfield>
    <subfield code="h">Hylarides, M.D.</subfield>
    <subfield code="h">Hamlin, D.K.</subfield>
    <subfield code="h">Wilbur, D.S.</subfield>
    <subfield code="h">Balkan, E.R.</subfield>
    <subfield code="h">Lin, Y.</subfield>
    <subfield code="h">Miller, B.W.</subfield>
    <subfield code="h">Frost, S.H.L.</subfield>
    <subfield code="h">Gopal, A.K.</subfield>
    <subfield code="h">Orozco, J.J.</subfield>
    <subfield code="h">Gooley, T.A.</subfield>
    <subfield code="h">Laird, K.L.</subfield>
    <subfield code="h">Till, B.G.</subfield>
    <subfield code="h">Bäck, T.</subfield>
    <subfield code="h">Sandmaier, B.M.</subfield>
    <subfield code="h">Pagel, J.M.</subfield>
    <subfield code="h">Press, O.W.</subfield>
    <subfield code="t">Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model</subfield>
    <subfield code="v">125</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">Green et al, 2015</subfield>
    <subfield code="s">Blood,125,2111</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Groppi, F.</subfield>
    <subfield code="h">Bonardi, M.L.</subfield>
    <subfield code="h">Birattari, C.</subfield>
    <subfield code="h">Menapace, E.</subfield>
    <subfield code="h">Abbas, K.</subfield>
    <subfield code="h">Holzwarth, U.</subfield>
    <subfield code="h">Alfarano, A.</subfield>
    <subfield code="h">Morzenti, S.</subfield>
    <subfield code="h">Zona, C.</subfield>
    <subfield code="h">Alfassi, Z.B.</subfield>
    <subfield code="t">Optimisation study of α-cyclotron production of At-211/Po-211g for high-let metabolic radiotherapy purposes</subfield>
    <subfield code="v">63</subfield>
    <subfield code="y">2005</subfield>
    <subfield code="o">Groppi et al, 2005</subfield>
    <subfield code="s">Appl.Radiat.Isot.,63,621</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Guerard, F.</subfield>
    <subfield code="h">Gestin, J.F.</subfield>
    <subfield code="h">Brechbiel, M.W.</subfield>
    <subfield code="t">Production of [211At]-astatinated radiopharmaceuticals and applications in targeted alpha-particle therapy</subfield>
    <subfield code="v">28</subfield>
    <subfield code="y">2013</subfield>
    <subfield code="o">Guerard et al, 2013</subfield>
    <subfield code="s">Cancer Biother.Radio.,28,1</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Hassfjell, S.</subfield>
    <subfield code="h">Brechbiel, M.W.</subfield>
    <subfield code="t">The development of the α-particle emitting radionuclides 212Bi and 213Bi, and their decay chain related radionuclides, for therapeutic applications</subfield>
    <subfield code="v">101</subfield>
    <subfield code="y">2001</subfield>
    <subfield code="o">Hassfjell and Brechbiel, 2001</subfield>
    <subfield code="s">Chem.Rev.,101,2019</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="p">IAEA</subfield>
    <subfield code="m">Technical Report Series No. 468: Cyclotron Produced Radionuclides: Physical Characteristics and Production Methods. International Atomic Energy Agency, Vienna</subfield>
    <subfield code="y">2009</subfield>
    <subfield code="9">refextract</subfield>
    <subfield code="o">IAEA, 2009</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Johnson, G.L.</subfield>
    <subfield code="h">Leininger, R.F.</subfield>
    <subfield code="h">Segre, E.</subfield>
    <subfield code="t">Chemical properties of Astatine</subfield>
    <subfield code="v">17</subfield>
    <subfield code="y">1949</subfield>
    <subfield code="o">Johnson et al, 1949</subfield>
    <subfield code="s">I.J.Chem.Phys.,17,1</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Johnston, H.S.</subfield>
    <subfield code="h">Graham, R.</subfield>
    <subfield code="t">Photochemistry of NOx and HNOx compounds</subfield>
    <subfield code="v">52</subfield>
    <subfield code="y">1974</subfield>
    <subfield code="o">Johnston and Graham, 1974</subfield>
    <subfield code="s">Can.J.Chem.,52,1415</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Jones, K.</subfield>
    <subfield code="t">Dinitrogen Trioxide, Pergamon Texts in Inorganic Chemistry Vol. II: The Chemistry of Nitrogen</subfield>
    <subfield code="p">Pergamon Press Oxford</subfield>
    <subfield code="y">1973</subfield>
    <subfield code="o">Jones, 1973</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Jurcic, J.G.</subfield>
    <subfield code="h">Larson, S.M.</subfield>
    <subfield code="h">Sgouros, G.</subfield>
    <subfield code="h">McDevitt, M.R.</subfield>
    <subfield code="h">Finn, R.D.</subfield>
    <subfield code="h">Divgi, C.R.</subfield>
    <subfield code="h">Ballangrud, Å.M.</subfield>
    <subfield code="h">Hamacher, K.A.</subfield>
    <subfield code="h">Ma, D.</subfield>
    <subfield code="h">Humm, J.L.</subfield>
    <subfield code="h">Brechbiel, M.W.</subfield>
    <subfield code="h">Molinet, R.</subfield>
    <subfield code="h">Scheinberg, D.A.</subfield>
    <subfield code="t">Targeted α particle immunotherapy for myeloid leukemia</subfield>
    <subfield code="v">100</subfield>
    <subfield code="y">2002</subfield>
    <subfield code="o">Jurcic et al, 2002</subfield>
    <subfield code="s">Blood,100,1233</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Klemenc, A.</subfield>
    <subfield code="t">Zur Kenntnis der Salpetersäure</subfield>
    <subfield code="v">280</subfield>
    <subfield code="y">1955</subfield>
    <subfield code="o">Klemenc, 1955</subfield>
    <subfield code="s">XI.Zeitsch Anorg.Allg.Chem.,280,100</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Lambrecht, R.M.</subfield>
    <subfield code="h">Mirzadeh, S.</subfield>
    <subfield code="t">Cyclotron isotopes and radiopharmaceuticals- XXXV. astatine-211</subfield>
    <subfield code="v">36</subfield>
    <subfield code="y">1985</subfield>
    <subfield code="o">Lambrecht and Mirzadeh, 1985</subfield>
    <subfield code="s">Int.J.Appl.Radiat.Isot.,36,443</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Lindegren, S.</subfield>
    <subfield code="h">Bäck, T.</subfield>
    <subfield code="h">Jensen, H.J.</subfield>
    <subfield code="t">Dry-distillation of astatine-211 from irradiated bismuth targets: a time-saving procedure with high recovery yields</subfield>
    <subfield code="v">55</subfield>
    <subfield code="y">2001</subfield>
    <subfield code="o">Lindegren et al, 2001</subfield>
    <subfield code="s">Appl.Radiat.Isot.,55,157</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">McDevitt, M.R.</subfield>
    <subfield code="h">Sgouros, G.</subfield>
    <subfield code="h">Finn, R.D.</subfield>
    <subfield code="h">Humm, J.L.</subfield>
    <subfield code="h">Jurcic, J.G.</subfield>
    <subfield code="h">Larson, S.M.</subfield>
    <subfield code="h">Scheinberg, D.A.</subfield>
    <subfield code="t">Radioimmunotherapy with alpha-emitting nuclides</subfield>
    <subfield code="v">25</subfield>
    <subfield code="y">1998</subfield>
    <subfield code="o">McDevitt et al, 1998</subfield>
    <subfield code="s">Eur.J.Nucl.Med.,25,1341</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Mulford, D.A.</subfield>
    <subfield code="h">Scheinberg, D.A.</subfield>
    <subfield code="h">Jurcic, J.G.</subfield>
    <subfield code="t">The promise of targeted alpha-particle therapy</subfield>
    <subfield code="v">46</subfield>
    <subfield code="y">2005</subfield>
    <subfield code="o">Mulford et al, 2005</subfield>
    <subfield code="s">J.Nucl.Med.,46,199S</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Neirinckx, R.D.</subfield>
    <subfield code="h">Smit, J.A.</subfield>
    <subfield code="t">Separation of astatine-211 from bismuth metal</subfield>
    <subfield code="v">63</subfield>
    <subfield code="y">1973</subfield>
    <subfield code="o">Neirinckx and Smit, 1973</subfield>
    <subfield code="s">Anal.Chim.Acta,63,201</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Neumann, H.M.</subfield>
    <subfield code="t">Solvent distribution studies of the chemistry of astatine</subfield>
    <subfield code="v">4</subfield>
    <subfield code="y">1957</subfield>
    <subfield code="o">Neumann, 1957</subfield>
    <subfield code="s">J.Inorg.Nucl.Chem.,4,349</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Orozco, J.J.</subfield>
    <subfield code="h">Back, T.</subfield>
    <subfield code="h">Kenoyer, A.</subfield>
    <subfield code="h">Balkin, E.R.</subfield>
    <subfield code="h">Hamlin, D.K.</subfield>
    <subfield code="h">Wilbur, D.S.</subfield>
    <subfield code="h">Fisher, D.R.</subfield>
    <subfield code="h">Frayo, S.L.</subfield>
    <subfield code="h">Hylarides, M.D.</subfield>
    <subfield code="h">Green, D.J.</subfield>
    <subfield code="h">Gopal, A.K.</subfield>
    <subfield code="h">Press, O.W.</subfield>
    <subfield code="h">Pagel, J.M.</subfield>
    <subfield code="t">Anti-CD45 radioimmunotherapy using 211At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model</subfield>
    <subfield code="v">121</subfield>
    <subfield code="y">2013</subfield>
    <subfield code="o">Orozco et al, 2013</subfield>
    <subfield code="s">Blood,121,3759</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Rosenblat, T.L.</subfield>
    <subfield code="h">McDevitt, M.R.</subfield>
    <subfield code="h">Mulford, D.A.</subfield>
    <subfield code="h">Pandit-Taskar, N.</subfield>
    <subfield code="h">Divgi, C.R.</subfield>
    <subfield code="h">Panageas, K.S.</subfield>
    <subfield code="h">Heaney, M.L.</subfield>
    <subfield code="h">Chanel, S.</subfield>
    <subfield code="h">Morgenstern, A.</subfield>
    <subfield code="h">Sgouros, G.</subfield>
    <subfield code="h">Larson, S.M.</subfield>
    <subfield code="h">Scheinberg, D.A.</subfield>
    <subfield code="h">Jurcic, J.G.</subfield>
    <subfield code="t">Sequential cytarabine and α-particle immunotherapy with bismuth-213–Lintuzumab (HuM195) for acute myeloid leukemia</subfield>
    <subfield code="v">16</subfield>
    <subfield code="y">2010</subfield>
    <subfield code="o">Rosenblat et al, 2010</subfield>
    <subfield code="s">Clin.Cancer Res.,16,5303</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Sultana, M.S.</subfield>
    <subfield code="h">Toyoshima, A.</subfield>
    <subfield code="h">Mito, A.</subfield>
    <subfield code="h">Takahashi, N.</subfield>
    <subfield code="h">Baba, H.</subfield>
    <subfield code="h">Watarai, H.</subfield>
    <subfield code="t">Solvent extraction behavior of astatine and radioiodine at tracer concentrations</subfield>
    <subfield code="v">243</subfield>
    <subfield code="y">2000</subfield>
    <subfield code="o">Sultana et al, 2000</subfield>
    <subfield code="s">J.Radio.Nucl.Chem.,243,631</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Vanysek, P.</subfield>
    <subfield code="m">-2015. Electrochemical Series, in: Haynes, W.M. (Ed Handbook of Chemistry and Physics, 95th ed. CRC Press, Boca Raton, FL, pp. 5-80 to 85-89</subfield>
    <subfield code="y">2014</subfield>
    <subfield code="9">refextract</subfield>
    <subfield code="o">Vanysek, 2014</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Wilbur, D.S.</subfield>
    <subfield code="t">[211At]Astatine-labeled compound stability: Issues with released [211At]astatide and development of labeling reagents to increase stability</subfield>
    <subfield code="v">1</subfield>
    <subfield code="y">2008</subfield>
    <subfield code="o">Wilbur, 2008</subfield>
    <subfield code="s">Curr.Radio.,1,144</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Wilbur, D.S.</subfield>
    <subfield code="t">Chemical and radiochemical considerations in radiolabeling with α-emitting radionuclides</subfield>
    <subfield code="v">4</subfield>
    <subfield code="y">2011</subfield>
    <subfield code="o">Wilbur, 2011</subfield>
    <subfield code="s">Curr.Radio.,4,214</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Wilbur, D.S.</subfield>
    <subfield code="h">Hadley, S.W.</subfield>
    <subfield code="h">Hines, J.J.</subfield>
    <subfield code="h">Atcher, R.W.</subfield>
    <subfield code="t">Assessment of dry distillation methods for improving protein labeling yields with astatine-211</subfield>
    <subfield code="v">30</subfield>
    <subfield code="y">1991</subfield>
    <subfield code="o">Wilbur et al, 1991</subfield>
    <subfield code="s">J.Label.Compd.Radio.,30,214</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Wooten, A.L., Chyan, M.-K., Hamlin, D.K.</subfield>
    <subfield code="m">Li, Y., Owsley, S.L Jr., Niver, C.M., Krzysko, A.J., O'Hara, M.J., Wilbur, D.S PEG column studies designed to eliminate nitric acid distillation in automation of the wet chemistry approach to isolation of astatine-211, In: Proceedings of the 16th International Workshop on Targetry and Target Chemistry, Santa Fe, NM, pp. 3</subfield>
    <subfield code="y">2016</subfield>
    <subfield code="9">refextract</subfield>
    <subfield code="o">Wooten et al, 2016</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Yordanov, A.T.</subfield>
    <subfield code="h">Pozzi, O.</subfield>
    <subfield code="h">Carlin, S.</subfield>
    <subfield code="h">Akabani, G.</subfield>
    <subfield code="h">Wieland, B.</subfield>
    <subfield code="h">Zalutsky, M.</subfield>
    <subfield code="t">Wet harvesting of no-carrier-added 211At from an irradiated 209Bi target for radiopharmaceutical applications</subfield>
    <subfield code="v">262</subfield>
    <subfield code="y">2004</subfield>
    <subfield code="o">Yordanov et al, 2004</subfield>
    <subfield code="s">J.Radio.Nucl.Chem.,262,593</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Zalutsky, M.R.</subfield>
    <subfield code="h">Pozzi, O.R.</subfield>
    <subfield code="t">Radioimmunotherapy with alpha-particle emitting radionuclides</subfield>
    <subfield code="v">48</subfield>
    <subfield code="y">2004</subfield>
    <subfield code="o">Zalutsky and Pozzi, 2004</subfield>
    <subfield code="s">Q.J.Nucl.Med.Mol.Imaging,48,289</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Zalutsky, M.R.</subfield>
    <subfield code="h">Pruszynski, M.</subfield>
    <subfield code="t">Astatine-211: production and availability</subfield>
    <subfield code="v">4</subfield>
    <subfield code="y">2011</subfield>
    <subfield code="o">Zalutsky and Pruszynski, 2011</subfield>
    <subfield code="s">Curr.Radio.,4,177</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Zalutsky, M.R.</subfield>
    <subfield code="h">Reardon, D.A.</subfield>
    <subfield code="h">Pozzi, O.R.</subfield>
    <subfield code="h">Vaidyanathan, G.</subfield>
    <subfield code="h">Bigner, D.D.</subfield>
    <subfield code="t">Targeted alpha-particle radiotherapy with 211At-labeled monoclonal antibodies</subfield>
    <subfield code="v">34</subfield>
    <subfield code="y">2007</subfield>
    <subfield code="o">Zalutsky et al, 2007</subfield>
    <subfield code="s">Nucl.Med.Biol.,34,779</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Zalutsky, M.R.</subfield>
    <subfield code="h">Reardon, D.A.</subfield>
    <subfield code="h">Akabani, G.</subfield>
    <subfield code="h">Coleman, R.E.</subfield>
    <subfield code="h">Friedman, A.H.</subfield>
    <subfield code="h">Friedman, H.S.</subfield>
    <subfield code="h">McLendon, R.E.</subfield>
    <subfield code="h">Wong, T.Z.</subfield>
    <subfield code="h">Bigner, D.D.</subfield>
    <subfield code="t">Clinical experience with α-particle–emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6</subfield>
    <subfield code="v">49</subfield>
    <subfield code="y">2008</subfield>
    <subfield code="o">Zalutsky et al, 2008</subfield>
    <subfield code="s">J.Nucl.Med.,49,30</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Zona, C.</subfield>
    <subfield code="h">Bonardi, M.L.</subfield>
    <subfield code="h">Groppi, F.</subfield>
    <subfield code="h">Morzenti, S.</subfield>
    <subfield code="h">Canella, L.</subfield>
    <subfield code="h">Persico, E.</subfield>
    <subfield code="h">Menapace, E.</subfield>
    <subfield code="h">Alfassi, Z.B.</subfield>
    <subfield code="h">Abbas, K.</subfield>
    <subfield code="h">Holzwarth, U.</subfield>
    <subfield code="h">Gibson, N.</subfield>
    <subfield code="t">Wet-chemistry method for the separation of no-carrier-added 211At/211gPo from 209Bi target irradiated by alpha-beam cyclotron</subfield>
    <subfield code="v">276</subfield>
    <subfield code="y">2008</subfield>
    <subfield code="o">Zona et al, 2008</subfield>
    <subfield code="s">J.Radio.Nucl.Chem.,276,819</subfield>
  </datafield>
  <datafield tag="FFT" ind1=" " ind2=" ">
    <subfield code="a">/afs/cern.ch/project/inspire/uploads/elsevier/consyn/consyn-files/0969-8043/S0969804317X0002X/S0969804316308831/S0969804316308831.xml</subfield>
    <subfield code="t">Elsevier</subfield>
    <subfield code="o">HIDDEN</subfield>
  </datafield>
</record>